Purpose: Transforming growth factor-beta1 (TGF-beta 1) is a major modulator
of cellular proliferation and extracellular matrix formation. We determine
d the role of TGF-beta 1 in invasion and metastasis in gastric cancer.
Materials and Methods: We detected TGF-beta 1 expression in primary and lym
ph node metastatic lesions of gastric cancer, using an antibody and in situ
hybridization. The plasma TGF-beta 1 levels in the peripheral vein and in
the tumor drainage vein were assayed.
Results: In the cytoplasm of cancer cells, TGF-beta 1 was immunostained in
35.9% (78 of 217) of primary gastric carcinomas, and this expression was co
nfirmed by in situ hybridization. Of 59 gastric carcinomas with a TGF-beta
1-negative primary tumor, metastatic lymph nodes were positive for TGF-beta
1 staining in 32 cases (54.2%). Positive staining of TGF-beta 1 in gastric
cancer tissues was closely related to serosal invasion, infiltrative growt
h, and lymph node metastasis. Multivariate analysis showed that the express
ion of TGF-beta 1 was an independent risk factor for serosal invasion and i
nfiltrative growth of the tumor. The plasma level of TGF-beta 1 did not dif
fer between TGF-beta 1-negative and -positive groups. There were also no di
fferences in plasma TGF-beta 1 levels among each tumor stage, between the p
eripheral and the tumor drainage veins, and between preoperative and postop
erative testings.
Conclusion: Transforming growth factor-beta 1 is closely related to the inv
asion and metastasis of gastric cancer, and production of TGF-beta 1 in the
tumor does not contribute to the total amount of TGF-beta 1 in the blood c
irculation. We interpret our observations to mean that in a tumor microenvi
ronment, TGF-beta 1 alters the biologic behavior of the tumor. (C) 1999 by
American Society of Clinical Oncology.